One of the mechanisms by which rTMS reverses the neurotoxicity of Alzheimer’s disease in mice may be by reversing the downregulation of the cAMP/PKA/CREB signalling pathway, which may be related to the mitochondrial energy metabolism of nerve cells. Here, CREB1 is linked to early-onset autosomal dominant Alzheimer disease.